SYNTHETIC DEMONSTRATION — no real student or patient. Not a medical device.

Hair loss

Why Is My Part Getting Wider? Understanding Hair Thinning in Women

A part that looks wider — more scalp showing, hair feeling less dense — is a common early sign of female pattern hair loss. Women tend to thin at the crown and along the part while the front hairline stays intact. Thyroid disease, iron deficiency, and hormonal shifts can look identical and should be ruled out.

Talk to a clinician

Nina Osei, NP — Nurse Practitioner

checkups, refills & skin. Gale can match you with a licensed clinician for a visit.

Find care →

Why does the part widen with female pattern hair loss?

A widening part is the hallmark presentation of female pattern hair loss (FPHL), also called androgenetic alopecia in women. In FPHL, hair follicles at the central and crown scalp gradually miniaturize under the influence of androgens and genetic predisposition — each successive hair that grows is finer, shorter, and less pigmented than the one before it. Because the density at the center scalp decreases while the frontal hairline is typically preserved, the part appears to grow wider 1.

FPHL is common: it affects an estimated 12% of women by age 30 and more than 50% of women over 70. It tends to accelerate during perimenopause and after menopause, when declining estrogen reduces a natural buffering effect on androgen-sensitive follicles 7. The condition is not a reflection of poor health — it has a strong genetic component and is not caused by anything you did.

What else can make the part look wider?

Several other conditions produce diffuse central thinning that widens the part, and they can coexist with FPHL:

Telogen effluvium — a stress-triggered shed in which a large proportion of follicles shift prematurely into the resting phase. Classic triggers include significant emotional or physical stress, major illness, surgery, rapid weight loss, nutritional deficiency, or childbirth (postpartum hair loss). Shedding typically starts two to four months after the trigger and may last several months before reversing 2.

Iron deficiency — low ferritin is one of the most common and underrecognized reversible causes of diffuse hair loss in women, particularly those with heavy menstrual periods or dietary restrictions. Ferritin levels in the lower half of the normal range can affect hair, even in the absence of frank anemia 4 5.

Thyroid disease — both hypothyroidism and hyperthyroidism cause diffuse telogen effluvium. A widening part alongside fatigue, weight change, or temperature sensitivity makes thyroid testing worthwhile 4.

PCOS and androgen excess — in women with polycystic ovary syndrome, elevated androgens can accelerate follicle miniaturization at the central scalp in a pattern resembling FPHL, often accompanied by irregular periods or acne 6.

What will a clinician look for?

A dermatologist will examine your scalp with dermoscopy to look for the pattern of hair shaft diameter variability and follicle miniaturization that characterizes FPHL, and to distinguish it from telogen effluvium and scarring conditions 1.

Blood tests are a standard part of the workup for diffuse hair loss in women and typically include TSH, ferritin and complete blood count, and (when clinically indicated) androgens such as free testosterone and DHEA-S 4. Hormonal testing is especially important when there are other signs of androgen excess or when PCOS is being considered 6.

If perimenopausal or postmenopausal symptoms are prominent, the clinician may also consider whether the hormonal transition is accelerating hair loss and whether hormonal options are relevant for the whole picture 7.

What treatment options are available?

The most established treatment for female pattern hair loss is topical minoxidil, applied directly to the scalp. A systematic review and meta-analysis of randomized controlled trials found that topical minoxidil 2% and 5% both significantly increase hair count in women with androgenetic alopecia compared to placebo, with 5% providing greater efficacy 3. It works best when started before extensive miniaturization has occurred, and requires sustained use to maintain results.

Low-level laser (light) therapy has emerging evidence as an adjunct approach for some patients. Platelet-rich plasma (PRP) injections have also been studied as an adjunct to other treatments — a meta-analysis of randomized controlled trials found PRP significantly increased hair density and thickness compared to control in androgenetic alopecia 8.

If a reversible cause is found — low iron, thyroid disease, or PCOS — correcting that cause should be the first step, since it may reduce or reverse the shedding. For menopausal women, the role of systemic or topical hormonal options can be discussed with a clinician, weighing the overall benefit-risk profile 7.

A dermatologist or endocrinologist can help determine the right combination of treatments based on the specific causes contributing to your hair thinning.

Common questions

Can postpartum hair loss cause a widening part?

Yes. Postpartum telogen effluvium is one of the most common forms of diffuse hair loss in women. During pregnancy, elevated estrogen prolongs the hair's growth phase; after delivery, levels drop sharply and a large cohort of follicles shift into the shedding phase together. This typically peaks around three to four months postpartum and is temporary — most women see regrowth within 6 to 12 months without treatment.

Is female pattern hair loss reversible?

FPHL is not fully reversible in the sense of permanently restoring original density — follicle miniaturization does not repair itself spontaneously. However, topical minoxidil and other treatments can stabilize loss and produce meaningful density improvement. Starting treatment earlier, before extensive miniaturization, gives the best results.

Could stopping birth control cause a widening part?

Yes. Stopping a combined oral contraceptive can trigger a temporary telogen effluvium two to four months after discontinuation, as the body adjusts to the loss of exogenous estrogen and progestins. This is usually self-limiting. Additionally, switching to a progestin-dominant contraceptive that has androgenic activity can accelerate FPHL in genetically predisposed women.

I am in my late 40s — is this just menopause?

Perimenopause and menopause are common contributors to accelerating female pattern hair loss, as declining estrogen reduces the natural buffer against androgen-sensitive follicles. However, thyroid disease, iron deficiency, and other conditions also become more common in this age range — all are worth ruling out with blood tests. A clinician can help identify what is driving the change and whether hormonal or other management options are appropriate for your overall picture.

Does minoxidil work for a widening part specifically?

Topical minoxidil has the best evidence for female pattern hair loss — the same condition that produces a widening central part. It works by prolonging the hair growth phase and increasing follicle size. Results take several months to appear, and the gains are maintained only with continued use. A 5% formulation applied once daily is FDA-approved for women.

Talk to a clinician

Nina Osei, NP — Nurse Practitioner

checkups, refills & skin. Gale can match you with a licensed clinician for a visit.

Find care →

Signs that warrant a faster evaluation

  • —Sudden or rapid widening of the part over weeks rather than months — may signal a more acute process
  • —Patchy loss alongside diffuse thinning — may suggest an additional diagnosis such as alopecia areata
  • —Scalp redness, itching, flaking, tenderness, or visible loss of follicle openings — possible scarring alopecia requiring urgent evaluation
  • —Hair thinning accompanied by significant fatigue, weight change, irregular periods, or mood changes — suggests a systemic or hormonal cause worth investigating promptly

This article provides general health information about hair thinning in women and is not a personalized medical diagnosis. Only a licensed clinician can evaluate the cause of your hair loss and recommend appropriate treatment.

References

  1. 1.Ioannides D, Lazaridou E (2015). Female pattern hair loss. Current Problems in Dermatology. doi:10.1159/000369404 ✓Female pattern hair loss causes gradual follicle miniaturization at the central scalp; widening part with preserved frontal hairline is the characteristic pattern
  2. 2.Rebora A (2019). Telogen effluvium: a comprehensive review. Clinical and Cosmetic Investigative Dermatology. doi:10.2147/CCID.S200471 ✓Telogen effluvium triggered by stressors causes diffuse shedding typically starting two to four months after the trigger, visible at the part
  3. 3.Adil A, Godwin M (2017). The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2017.02.054 ✓Topical minoxidil is the most established treatment for female pattern hair loss, most effective when started before extensive thinning
  4. 4.Jonklaas J, Bianco AC, Bauer AJ, et al. (2014). Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. doi:10.1089/thy.2014.0028 ✓Thyroid dysfunction is a common and treatable cause of diffuse hair thinning in women; thyroid testing is standard in any hair loss evaluation
  5. 5.Leung AKC, Lam JM, Wong AHC, Hon KL, Li X (2024). Iron Deficiency Anemia: An Updated Review. Current Pediatric Reviews. doi:10.2174/1573396320666230727102042 ✓Low ferritin is a common underrecognized cause of hair loss in women, especially those with heavy menstrual periods
  6. 6.American College of Obstetricians and Gynecologists (2018). ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000002656 ✓PCOS-related androgen excess is a cause of scalp hair thinning in women and is evaluated via hormonal panel
  7. 7.Faubion SS, Crandall CJ, Davis L, El Khoudary SR, Hodis HN, Lobo RA, Maki PM, Manson JE, Pinkerton JV, Santoro NF, Shifren JL, Shufelt CL, Thurston RC, Wolfman W (2022). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. doi:10.1097/GME.0000000000002028 ✓Perimenopause and declining estrogen accelerate female pattern hair loss; hormonal management options exist and differ by menopausal status
  8. 8.Zhang X, Ji Y, Zhou M, Zhou X, Xie Y, Zeng X, Shao F, Zhang C (2023). Platelet-Rich Plasma for Androgenetic Alopecia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Cutaneous Medicine and Surgery. doi:10.1177/12034754231191461 ✓PRP injections are used as an adjunct procedure for androgenetic alopecia with supporting evidence

8 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.